ProPhase Labs Inc.

NASDAQ: PRPH · Real-Time Price · USD
0.34
-0.02 (-5.03%)
At close: Jun 09, 2025, 3:59 PM

ProPhase Labs Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-49.52M -16.78M 18.46M 6.27M
Depreciation & Amortization
6.64M 6.7M 5.06M 3.56M
Stock-Based Compensation
3.64M 3.54M 3.99M 3.18M
Other Working Capital
3.73M -10.03M 577K 2.88M
Other Non-Cash Items
-334K 896K 5.52M -311K
Deferred Income Tax
7.15M n/a -138K 557K
Change in Working Capital
14.89M -5.7M -4.34M -26.88M
Operating Cash Flow
-17.54M -11.35M 28.55M -13.62M
Capital Expenditures
-906K -3.15M -3.92M -4.23M
Cash Acquisitions
n/a -2.9M 452K -9.07M
Purchase of Investments
n/a -3.82M -6.78M -21.53M
Sales Maturities Of Investments
3.37M 7.99M 8.17M 15.86M
Other Investing Acitivies
-46K 524K 1.84M -700K
Investing Cash Flow
2.42M -1.37M -2.08M -19.67M
Debt Repayment
5.61M 10.52M -7.04M -45K
Common Stock Repurchased
n/a -5.97M -9.63M -917K
Dividend Paid
n/a n/a -9.35M -4.55M
Other Financial Acitivies
978K 1.2M -7.47M n/a
Financial Cash Flow
14.19M 5.76M -26.02M 35.13M
Net Cash Flow
-931K -6.96M 451K 1.84M
Free Cash Flow
-18.44M -14.5M 24.63M -17.85M